Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA

PURPOSE: To evaluate prostate-cancer specific mortality (PCSM) in a cohort of high-risk patients treated with a permanent prostate brachytherapy approach, stratified by pre-treatment PSA. MATERIAL AND METHODS: 448 high-risk patients (NCCN criteria) underwent permanent prostate brachytherapy. High ri...

Descripción completa

Detalles Bibliográficos
Autores principales: Merrick, Gregory S., Galbreath, Robert W., Butler, Wayne M., Fiano, Ryan, Adamovich, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611460/
https://www.ncbi.nlm.nih.gov/pubmed/28951747
http://dx.doi.org/10.5114/jcb.2017.69588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611460/
https://www.ncbi.nlm.nih.gov/pubmed/28951747
http://dx.doi.org/10.5114/jcb.2017.69588

Ejemplares similares